Like Sands Through The Hourglass, So Are The Days Of Woodcock’s Acting FDA Commissionership

 
• By Derrick Gingery

Janet Woodcock has been a no-nonsense acting commissioner, but there’s plenty of drama in the nomination process as opposition and support for her to become permanent head of the US FDA continues to mount while the wait for President Biden’s nominee drags on.

Unless the Biden administration nominates someone by 16 November, Janet Woodcock is halfway through her tenure as acting commissioner of the US FDA. • Source: photo illustration/Alamy images

More from US FDA

More from Agency Leadership